[
    [
        {
            "time": "2023-04-15",
            "original_text": "The Vanguard Health Care Fund Exits CVS Health, Teva Pharmaceutical",
            "features": {
                "keywords": [
                    "Vanguard",
                    "Health Care Fund",
                    "Exits",
                    "CVS Health",
                    "Teva Pharmaceutical"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "The Vanguard Health Care Fund Exits CVS Health, Teva Pharmaceutical",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "Lilly to Participate in UBS Virtual Global Healthcare Conference",
            "features": {
                "keywords": [
                    "Lilly",
                    "UBS",
                    "Virtual Global Healthcare Conference"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Lilly to Participate in UBS Virtual Global Healthcare Conference",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "LLY",
                    "Outpaced",
                    "Medical Stocks"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year?",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "Incyte (INCY) Misses Q1 Earnings Estimates, Beats on Revenues",
            "features": {
                "keywords": [
                    "Incyte",
                    "INCY",
                    "Misses",
                    "Q1 Earnings",
                    "Beats",
                    "Revenues"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Incyte (INCY) Misses Q1 Earnings Estimates, Beats on Revenues",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates",
            "features": {
                "keywords": [
                    "Henry Schein",
                    "HSIC",
                    "Q1 Earnings",
                    "Revenues",
                    "Top Estimates"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Henry Schein (HSIC) Q1 Earnings and Revenues Top Estimates",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-15",
            "original_text": "Tandem Diabetes (TNDM) Q1 Loss Widens, Revenues Top Estimates",
            "features": {
                "keywords": [
                    "Tandem Diabetes",
                    "TNDM",
                    "Q1 Loss",
                    "Widens",
                    "Revenues",
                    "Top Estimates"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Tandem Diabetes (TNDM) Q1 Loss Widens, Revenues Top Estimates",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]